Viewing Study NCT01739933

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-03-22 @ 11:05 AM
Study NCT ID: NCT01739933
Status: COMPLETED
Last Update Posted: 2021-06-07
First Post: 2012-11-28
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure
Sponsor: Vanderbilt University Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sepsis View
None Delirium View
None Impaired Cognition View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Delirium View
None Delirium/coma-free days View
None Long term cognitive impairment View
None Sedation View
None Intensive care View
None Mechanical Ventilation View
None Dexmedetomidine View
None Propofol View
None Coma-free days View
None Sepsis View
None Organ dysfunction View
None Acute Respiratory Distress View
None Markers of inflammation View